Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | STML | AMGN | GILD | CELG | VRTX |
| Company | Stemline Therapeutic | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 12.00 | 337.03 | 84.39 | 108.01 | 477.70 |
| High | 12.10 | 338.70 | 84.65 | 108.59 | 482.04 |
| Low | 11.82 | 334.61 | 83.57 | 107.27 | 476.27 |
| Last | 11.83 | 337.14 | 84.62 | 108.24 | 481.60 |
| Change | -0.17 | +4.22 | +0.73 | +0.11 | +7.44 |
| % Change | -1.42% | +1.27% | +0.87% | +0.10% | +1.57% |
| Volume | 17,354,300 | 589,550 | 3,317,842 | 191,230,496 | 355,429 |
| 20-Day Average Volume | 2,076,345 | 1,707,250 | 6,413,796 | 16,188,930 | 956,834 |
| Previous Close | 12.00 | 332.92 | 83.89 | 108.13 | 474.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.96 | 329.62 | 80.10 | 108.17 | 480.01 |
| 20-Day Raw Stochastic | 25.45% | 88.15% | 94.81% | 63.25% | 50.63% |
| 20-Day Relative Strength | 69.80% | 58.17% | 72.81% | 64.69% | 50.80% |
| Weighted Alpha | -54.90 | +27.45 | +19.20 | +46.30 | +34.63 |
| Today's Opinion | 56% Buy | 96% Buy | 88% Buy | 100% Buy | 56% Buy |
| Previous Opinion | 72% Buy | 88% Buy | 88% Buy | 100% Buy | 40% Buy |
| Last Month's Opinion | 16% Buy | 88% Buy | 56% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.92% since 06/02/20 | +1.99% since 09/12/24 | +1.49% since 09/12/24 | -1.97% since 11/13/19 | +0.43% since 09/12/24 |
| Low | 11.82 on 06/09/20 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 107.27 on 11/20/19 | 473.75 on 09/18/24 |
| High | 12.17 on 06/03/20 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 110.53 on 11/14/19 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | -2.87% since 05/08/20 | +2.64% since 08/19/24 | +13.36% since 08/19/24 | +5.14% since 10/18/19 | -1.50% since 08/19/24 |
| Low | 11.69 on 05/27/20 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 102.40 on 10/21/19 | 460.69 on 09/11/24 |
| High | 12.25 on 05/11/20 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | +134.72% since 03/09/20 | +10.01% since 06/18/24 | +33.64% since 06/18/24 | +13.63% since 08/20/19 | +2.88% since 06/18/24 |
| Low | 3.21 on 03/18/20 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 93.41 on 08/23/19 | 458.04 on 08/13/24 |
| High | 12.35 on 05/04/20 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | +19.37% since 12/09/19 | +23.88% since 03/19/24 | +14.96% since 03/19/24 | +14.14% since 05/20/19 | +15.78% since 03/19/24 |
| Low | 3.21 on 03/18/20 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 391.01 on 04/18/24 |
| High | 12.35 on 05/04/20 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 621,205 | 178,589,936 | 104,514,608 | 77,035,920 | 122,358,416 |
| Shares Outstanding, K | 52,511 | 536,435 | 1,245,853 | 711,714 | 258,053 |
| Annual Sales | 43,220,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -76,820,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 8,870,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 2,645,600,000 |
| Last Quarter Net Income | -21,290,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -3,593,600,000 |
| 60-Month Beta | 1.78 | 0.61 | 0.18 | 1.41 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | -12.83 on 08/01/24 |
| Latest Earnings Date | 06/05/20 | 10/29/24 | 11/05/24 | 10/31/19 | 11/04/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 10.99 | 0.00 |